Stocks and Investing
Stocks and Investing
Mon, August 19, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, August 16, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (catx) at Buy with Decreased Target to $27 on, Aug 16th, 2024
Gregory Renza of RBC Capital, Maintained "Perspective Therapeutics, Inc." (CATX) at Buy with Decreased Target from $29 to $27 on, Aug 16th, 2024.
Gregory has made no other calls on CATX in the last 4 months.
There are 4 other peers that have a rating on CATX. Out of the 4 peers that are also analyzing CATX, 0 agree with Gregory's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Gregory
- Jeff Jones of "Oppenheimer" Maintained at Buy with Decreased Target to $17 on, Tuesday, August 13th, 2024
- Alec Stranahan of "B of A Securities" Initiated at Strong Buy and Held Target at $24 on, Thursday, July 25th, 2024
- Louis Chen of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, June 25th, 2024
- Justin Walsh of "Jones Trading" Maintained at Strong Buy with Increased Target to $22 on, Thursday, May 16th, 2024
Contributing Sources